RANI Earnings & Financial Statements
Rani Therapeutics Holdings, Inc.
$0.68
+$0.01(+1.46%)
32
Overall
40
Value
10
Tech
47
Quality
Market Cap
$93.42M
Volume
439.17K
52W Range
$0.45 - $3.87
Target Price
$7.17
RANI earnings and financial statements: Rani Therapeutics Holdings, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
RANI Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.63M | $1.03M | - | - | $2.72M |
| Operating income | -$38.31M | -$53.31M | -$66.10M | -$63.45M | -$51.60M |
| EBITDA | -$35.04M | -$48.48M | -$60.70M | -$61.66M | -$52.08M |
| Net income | -$29.67M | -$30.02M | -$33.97M | -$30.59M | -$8.33M |
| EPS (diluted) | $-0.45 | $-1.05 | $-1.33 | $-1.28 | $-0.43 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $58.62M | $36.63M | $57.92M | $108.03M | $124.21M |
| Total liabilities | $17.11M | $33.14M | $32.47M | $34.02M | $2.64M |
| Shareholders’ equity | $33.01M | $1.99M | $12.87M | $36.85M | $47.41M |
| Cash and equivalents | $18.62M | $3.76M | $5.86M | $27.01M | $117.45M |
| Long-term debt | $2.73M | $13.25M | $24.48M | $29.21M | - |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$18.71M | -$35.50M | -$51.24M | -$46.52M | -$32.24M |
| Capital expenditure | -$88.0K | -$268.0K | -$1.23M | -$1.62M | -$506.0K |
| Free cash flow | -$18.80M | -$35.76M | -$52.47M | -$48.13M | -$32.75M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RANI | $0.68 | +1.5% | 439.17K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rani Therapeutics Holdings, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW